Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome
暂无分享,去创建一个
Nilesh J Samani | Panos Deloukas | Jeanette Erdmann | Heribert Schunkert | Christian Hengstenberg | Scott Nankervis | Alison H Goodall | Christopher P Nelson | Mark J Cowley | P. Deloukas | M. Jobling | W. Ouwehand | N. Samani | A. Balmforth | A. Hall | A. Dominiczak | J. Erdmann | C. Hengstenberg | F. Cambien | H. Schunkert | C. Nelson | M. Cowley | M. Denniff | I. Ford | C. Packard | A. Goodall | Ahmed Bani‐Mustafa | M. Tomaszewski | F. Charchar | T. Barnes | Ian Ford | Anthony J Balmforth | Francois Cambien | Willem H Ouwehand | Yanzhong Wang | Alistair S Hall | Maciej Tomaszewski | Anna F Dominiczak | Fadi J Charchar | Mark A Jobling | R. Debiec | Chris Packard | Matthew Denniff | Lisa DS Bloomer | Timothy A Barnes | Yanzhong Wang | Radoslaw Debiec | Paraskevi Christofidou | Ahmed Bani-Mustafa | P. Christofidou | L. D. Bloomer | S. Nankervis | C. Nelson
[1] C. Gieger,et al. Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.
[2] R. Kraemer. Regulation of cell migration in atherosclerosis , 2000, Current atherosclerosis reports.
[3] Y. Zhong,et al. Low responder T cell susceptibility to the suppressive function of regulatory T cells in patients with dilated cardiomyopathy , 2010, Heart.
[4] L. Curtiss. Reversing atherosclerosis? , 2009, The New England journal of medicine.
[5] J. Graves,et al. How the gene content of human sex chromosomes evolved. , 2006, Current opinion in genetics & development.
[6] L L Cavalli-Sforza,et al. The genetic legacy of Paleolithic Homo sapiens sapiens in extant Europeans: a Y chromosome perspective. , 2000, Nature Reviews Genetics.
[7] S. Vollset. Does the southern European cardiovascular mortality advantage extend to total mortality? 50-year trends in death risks between 40 and 70 years of age in Western European men and women , 2010, Scandinavian journal of public health.
[8] William D. Lees,et al. Defective acute inflammation in Crohn's disease: a clinical investigation , 2006, The Lancet.
[9] P. Meikle,et al. Glycosaminoglycan degradation fragments in mucopolysaccharidosis I. , 2004, Glycobiology.
[10] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[11] Michael L. Creech,et al. Integration of biological networks and gene expression data using Cytoscape , 2007, Nature Protocols.
[12] Philippa J. Talmud,et al. Utility of genetic determinants of lipids and cardiovascular events in assessing risk , 2011, Nature Reviews Cardiology.
[13] J. Connell,et al. The Y Chromosome Effect on Blood Pressure in Two European Populations , 2002, Hypertension.
[14] S. Harrap,et al. Association of the Human Y Chromosome With High Blood Pressure in the General Population , 2000, Hypertension.
[15] N. Mehta. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. , 2011, Circulation. Cardiovascular genetics.
[16] G. Lowe,et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. , 2000, The New England journal of medicine.
[17] Thomas W. Mühleisen,et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease , 2011, Nature Genetics.
[18] Chris Tyler-Smith,et al. The human Y chromosome: an evolutionary marker comes of age , 2003, Nature Reviews Genetics.
[19] A. Dominiczak,et al. Studies of an association in boys of blood pressure and the Y chromosome. , 2007, American journal of hypertension.
[20] E. Eriksson. Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects , 2004, Current opinion in lipidology.
[21] P. Burton,et al. A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study. , 2005, American journal of human genetics.
[22] M. Jobling,et al. Founders, Drift, and Infidelity: The Relationship between Y Chromosome Diversity and Patrilineal Surnames , 2009, Molecular biology and evolution.
[23] Daniel Levy,et al. Lifetime risk of developing coronary heart disease , 1999, The Lancet.
[24] D. Goldstein,et al. A Y Chromosome Census of the British Isles , 2003, Current Biology.
[25] P. Macfarlane,et al. West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996 .
[26] Martin Vingron,et al. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk , 2010, Nature.
[27] T. Graves,et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes , 2003, Nature.
[28] Hui Liu,et al. CADgene: a comprehensive database for coronary artery disease genes , 2010, Nucleic Acids Res..
[29] Mark I. McCarthy,et al. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease , 2011, Nature Genetics.
[30] Andrew Pekosz,et al. The Xs and Y of immune responses to viral vaccines. , 2010, The Lancet. Infectious diseases.
[31] A. Redd,et al. A nomenclature system for the tree of human Y-chromosomal binary haplogroups. , 2002, Genome research.
[32] V. Bajic,et al. Multi-Organ Expression Profiling Uncovers a Gene Module in Coronary Artery Disease Involving Transendothelial Migration of Leukocytes and LIM Domain Binding 2: The Stockholm Atherosclerosis Gene Expression (STAGE) Study , 2009, PLoS genetics.
[33] Enrique Sanchez-Delgado,et al. Lifetime risk of developing coronary heart disease , 1999, The Lancet.
[34] A. Dominiczak,et al. Association of the Human Y Chromosome with Cholesterol Levels in the General Population , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[35] A. Gotlieb,et al. Common pathogenic features of atherosclerosis and calcific aortic stenosis: role of transforming growth factor-beta. , 2010, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[36] Gary D Bader,et al. Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.
[37] P. Hordijk,et al. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases , 2009, Journal of leukocyte biology.
[38] L. Marnell,et al. C-reactive protein at the interface between innate immunity and inflammation , 2008, Expert review of clinical immunology.
[39] J. Goedert,et al. Association of Y chromosome haplogroup I with HIV progression, and HAART outcome , 2009, Human Genetics.
[40] Peter Libby,et al. The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.
[41] Anne Cambon-Thomsen,et al. Phylogeography of Y-chromosome haplogroup I reveals distinct domains of prehistoric gene flow in europe. , 2004, American journal of human genetics.
[42] D. A. Hanson,et al. Focal adhesion kinase: in command and control of cell motility , 2005, Nature Reviews Molecular Cell Biology.
[43] Ames,et al. PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA , 2000 .
[44] F. Mach,et al. Leukocyte recruitment in atherosclerosis: Potential targets for therapeutic approaches? , 2006, Cellular and Molecular Life Sciences CMLS.
[45] Simon C. Potter,et al. Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease , 2011, PLoS genetics.
[46] Marian Brennan,et al. Integrins as therapeutic targets: lessons and opportunities , 2010, Nature Reviews Drug Discovery.
[47] M. Turner,et al. Review of the Y chromosome, Sry and hypertension , 2010, Steroids.
[48] B. Staels,et al. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. , 2000, Biochemical pharmacology.
[49] H. Tunón,et al. Laxatives and the Ice Man , 1999, The Lancet.
[50] S. Tzartos,et al. The gender gap in autoimmune disease , 2001, The Lancet.
[51] A. Tedgui,et al. Cytokines in atherosclerosis: pathogenic and regulatory pathways. , 2006, Physiological reviews.
[52] N. Wald,et al. When can a risk factor be used as a worthwhile screening test? , 1999, BMJ.
[53] A. Dominiczak,et al. Y is there a risk to being male? , 2003, Trends in Endocrinology & Metabolism.
[54] Guido Barbujani,et al. A Predominantly Neolithic Origin for European Paternal Lineages , 2010, PLoS biology.
[55] Karen M. Kaufmann. The Gender Gap , 2006, PS: Political Science & Politics.
[56] A. Swerdlow,et al. Mortality and cancer incidence in males with Y polysomy in Britain: a cohort study , 2007, Human Genetics.
[57] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[58] D. Absher,et al. Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-Wide Association Meta-analysis Involving More Than 22 000 Cases and 60 000 Controls , 2010, Circulation. Cardiovascular genetics.
[59] N. Samani,et al. Socioeconomic status and telomere length: the West of Scotland Coronary Prevention Study , 2009, Journal of Epidemiology & Community Health.